Ben Zvi Shmuel
SEC insider (Form 3/4/5 filer). CIK 0001935668. Director at Protalix BioTherapeutics, Inc. (PLX). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in CARMIEL.
Companies Ben Zvi Shmuel has filed insider reports for
- Protalix BioTherapeutics, Inc. (PLX): Director
Ben Zvi Shmuel
CIK: 0001935668
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PLX
Protalix BioTherapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 3, 2026PLX
Protalix BioTherapeutics, Inc.
AwardDirectStock Options (Right to Buy)
17K shares- - Sep 3, 2026PLX
Protalix BioTherapeutics, Inc.
AwardDirectRestricted Stock Units
8.5K shares- - Sep 3, 2025PLX
Protalix BioTherapeutics, Inc.
AwardIndirect7.5K shares-
1-3 of 3 transactions